Management of cocaine abuse and dependence.

During the 20th century, there have been recurrent episodes of cocaine abuse in the United States that have achieved epidemic proportions.1 Although the total number of people using the drug has decreased in the past decade, cocaine-related biomedical and psychosocial problems remain a major public health problem in the United States and many other countries. The expanding list of cocaine-related toxic effects, acute and chronic, includes reproductive dysfunction, hepatic necrosis, and pulmonary disease.2 Abuse of and dependence on cocaine may also be associated with disorders of sexual function, sleep, anxiety, and mood, as well as with delirium and psychotic disorders. . . .

[1]  J. Mendelson,et al.  Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  T. Kosten,et al.  Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. , 1992, Archives of general psychiatry.

[3]  S. Feldman,et al.  Differential effects of medial forebrain bundle lesions on adrenocortical responses following limbic stimulation , 1983, Neuroscience.

[4]  W. Feuerlein,et al.  [Drug addiction and drug abuse]. , 1969, Munchener medizinische Wochenschrift.

[5]  M. Chadwick,et al.  A double-blind amino acids, L-tryptophan and L-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center. , 1990, The American journal of drug and alcohol abuse.

[6]  K. Preston,et al.  Effects of cocaine alone and in combination with mazindol in human cocaine abusers. , 1993, The Journal of pharmacology and experimental therapeutics.

[7]  H. Kleber,et al.  Psychopharmacological trials in cocaine abuse treatment. , 1986, The American journal of drug and alcohol abuse.

[8]  J. Mendelson,et al.  Buprenorphine pharmacotherapy for concurrent heroin and cocaine dependence. , 1993 .

[9]  G. Badger,et al.  Achieving cocaine abstinence with a behavioral approach. , 1993, The American journal of psychiatry.

[10]  B. Rounsaville,et al.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.

[11]  B. Rounsaville,et al.  A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. , 1991, The American journal of drug and alcohol abuse.

[12]  A. Leon,et al.  Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. , 1995, The New England journal of medicine.

[13]  H. Kleber,et al.  Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. , 1985, The American journal of drug and alcohol abuse.

[14]  W. Ling,et al.  Cocaine abuse treatment: a review of current strategies. , 1991, Journal of substance abuse.

[15]  L. Cregler,et al.  Medical complications of cocaine abuse. , 1986, The New England journal of medicine.

[16]  J. Wilkins,et al.  A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. , 1995, Drug and alcohol dependence.

[17]  A. Giannini,et al.  Bromocriptine Therapy in Cocaine Withdrawal , 1987, Journal of clinical pharmacology.

[18]  K. Johnson,et al.  Neurobiology of cocaine abuse. , 1992, Trends in pharmacological sciences.

[19]  R. Weiss,et al.  The Role of Psychotherapy in the Treatment of Substance‐Use Disorders , 1994, Harvard review of psychiatry.

[20]  J. Jaffe,et al.  Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. , 1992, The International journal of the addictions.

[21]  N. Mello A Behavioral Analysis of the Reinforcing Properties of Alcohol and Other Drugs in Man , 1983 .

[22]  P. Jatlow,et al.  Desipramine facilitation of initial cocaine abstinence. , 1989, Archives of general psychiatry.

[23]  P. Devenyi,et al.  Bromocriptine in cocaine withdrawal--does it work? , 1988, The International journal of the addictions.

[24]  H. Kleber,et al.  Pharmacologic treatments of cocaine abuse. , 1986, The Psychiatric clinics of North America.

[25]  G. Badger,et al.  Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. , 1994, Archives of general psychiatry.

[26]  J. Mendelson,et al.  Effects of cocaine on pulsatile activity of hypothalamic-pituitary-adrenal axis in male rhesus monkeys: neuroendocrine and behavioral correlates. , 1996, The Journal of pharmacology and experimental therapeutics.

[27]  T. Kosten,et al.  Bromocriptine treatment of cocaine abuse in patients maintained on methadone. , 1988, The American journal of psychiatry.

[28]  P. Jatlow,et al.  Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. , 1994, Archives of general psychiatry.

[29]  C. O'brien,et al.  Carbamazepine treatment for cocaine dependence. , 1995, Drug and alcohol dependence.

[30]  M. Gold,et al.  Single-dose bromocriptine reverses cocaine craving , 1987, Psychiatry Research.

[31]  L. Bauer,et al.  Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. , 1995, Drug and alcohol dependence.

[32]  T. Kosten,et al.  A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. , 1987, The Journal of clinical psychiatry.

[33]  D. Gorelick,et al.  Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. , 1995, Drug and alcohol dependence.

[34]  P. Selwyn,et al.  Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.

[35]  D. Ziedonis,et al.  Buprenorphine versus Methadone Maintenance for Opioid Dependence , 1993, The Journal of nervous and mental disease.

[36]  A T McLellan,et al.  An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients: The Addiction Severity Index , 1980, The Journal of nervous and mental disease.

[37]  J. Halikas,et al.  CARBAMAZEPINE FOR COCAINE ADDICTION? , 1989, The Lancet.

[38]  Mendelson Jh,et al.  Medical progress. Biologic concomitants of alcoholism. , 1979 .

[39]  R. Spealman,et al.  Antagonism of cocaine self‐administration by selective dopamine D1 and D2 antagonists , 1990, Behavioural pharmacology.

[40]  J. Crayton,et al.  Current pharmacotherapies for cocaine abuse: a review. , 1993, Journal of addictive diseases.

[41]  E. Nestler,et al.  Molecular Neurobiology of Drug Addiction , 1994, Neuropsychopharmacology.

[42]  D. Ziedonis,et al.  Buprenorphine: Dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans , 1993, Biological Psychiatry.

[43]  M W Fischman,et al.  The pharmacology of cocaine related to its abuse. , 1989, Pharmacological reviews.

[44]  J. Mendelson,et al.  Acute effects of cocaine on prolactin and gonadotropins in female rhesus monkey during the follicular phase of the menstrual cycle. , 1990, The Journal of pharmacology and experimental therapeutics.

[45]  T. Kosten,et al.  Role of opioid antagonists in treating intravenous cocaine abuse. , 1989, Life sciences.

[46]  A. Alterman,et al.  Amantadine may facilitate detoxification of cocaine addicts. , 1992, Drug and alcohol dependence.

[47]  R. Ehrman,et al.  Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. , 1990, Addictive behaviors.

[48]  P. Goldman-Rakic,et al.  Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association. , 1995, The American journal of psychiatry.

[49]  T. Crowley,et al.  Use of contingency contracts in specialty clinics for cocaine abuse. , 1982, NIDA research monograph.

[50]  C. Johanson Why publish three negative articles on carbamazepine as a medication for the treatment of cocaine dependence? , 1995, Drug and alcohol dependence.

[51]  H. Kleber,et al.  Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate. , 1984, Archives of general psychiatry.

[52]  M. Sanfilipo,et al.  A Placebo-Controlled Trial of L-DOPA/Carbidopa in Early Cocaine Abstinence , 1993, Neuropsychopharmacology.

[53]  C. McDougle,et al.  Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. , 1991, The American journal of psychiatry.

[54]  J. Mendelson,et al.  Buprenorphine suppresses cocaine self-administration in rhesus monkeys. , 1989, NIDA research monograph.

[55]  A. Falek,et al.  Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. , 1988, Advances in biochemical psychopharmacology.

[56]  M. Winniford,et al.  Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. , 1994, The New England journal of medicine.

[57]  F. Gawin,et al.  Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report. , 1989, Archives of general psychiatry.

[58]  Gawin Fh,et al.  Cocaine abuse: a review of current and experimental treatments. , 1984, NIDA research monograph.

[59]  R. Meyer,et al.  The Heroin Stimulus , 1979, Springer US.

[60]  David F. Musto,et al.  The American disease : origins of narcotic control , 1974 .

[61]  G. Badger,et al.  Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence. , 1994, The American journal of drug and alcohol abuse.

[62]  H. Kleber,et al.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. , 1986, Archives of general psychiatry.

[63]  R. Spealman,et al.  Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine , 1992, Neurochemistry International.

[64]  J. Mendelson,et al.  Acute Interactions of Buprenorphine with Intravenous Cocaine and Morphine: An Investigational New Drug Phase I Safety Evaluation , 1993, Journal of clinical psychopharmacology.

[65]  M. Kuhar,et al.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.

[66]  S. B. Caine,et al.  Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. , 1993, Science.

[67]  J. Mendelson,et al.  Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys. , 1993, The Journal of pharmacology and experimental therapeutics.

[68]  B. Ho,et al.  Neurochemical effects of cocaine following acute and repeated injection , 1977, Journal of neuroscience research.

[69]  M. Viederman Grief: normal and pathological variants. , 1995, The American journal of psychiatry.

[70]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[71]  L. Parsons,et al.  Suppression of psychoactive effects of cocaine by active immunization , 1995, Nature.

[72]  D. Landry,et al.  Antibody-catalyzed degradation of cocaine. , 1993, Science.

[73]  R. Chaisson,et al.  Cocaine use and HIV infection in intravenous drug users in San Francisco. , 1989, JAMA.

[74]  J. Gfroerer,et al.  Frequent cocaine users and their use of treatment. , 1993, American journal of public health.

[75]  R. Herning,et al.  Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. , 1990, Archives of general psychiatry.

[76]  W. Bickel,et al.  Buprenorphine treatment of opioid dependence: A review. , 1995 .

[77]  J. Hollander The management of cocaine-associated myocardial ischemia. , 1995, The New England journal of medicine.

[78]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[79]  J. Feather,et al.  Bromocriptine and amantadine in cocaine detoxification , 1989, Psychiatry Research.

[80]  J. Mendelson,et al.  Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[81]  P. Thompson,et al.  Acute cardiac events temporally related to cocaine abuse. , 1986, The New England journal of medicine.

[82]  M. Kuhar NEUROTRANSMITTER TRANSPORTERS AS DRUG TARGETS : RECENT RESEARCH WITH A FOCUS ON THE DOPAMINE TRANSPORTER , 1993 .

[83]  W. Vale,et al.  Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism , 1987, Brain Research.

[84]  J. Fairbank,et al.  Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. , 1991, Journal of substance abuse treatment.

[85]  W. Bickel,et al.  Applying behavioral concepts and principles to the treatment of cocaine dependence. , 1994, Drug and alcohol dependence.

[86]  F. Gawin Chronic neuropharmacology of cocaine: progress in pharmacotherapy. , 1988, The Journal of clinical psychiatry.

[87]  J. Mendelson Biologic Concomitants of Alcoholism , 1970 .

[88]  A. Alterman,et al.  Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.

[89]  M. Gold,et al.  Psychopharmacology of Cocaine , 1988 .

[90]  F. Tennant,et al.  Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. , 1987, Archives of internal medicine.

[91]  Tennant Fs,et al.  Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. , 1984 .

[92]  J. Mendelson,et al.  Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. , 1992, The Journal of pharmacology and experimental therapeutics.

[93]  R. Foltin,et al.  Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. , 1991, The Journal of pharmacology and experimental therapeutics.

[94]  P. Jatlow,et al.  Cocaethylene: pharmacology, physiology and behavioral effects in humans. , 1995, The Journal of pharmacology and experimental therapeutics.

[95]  D. Marlowe,et al.  Psychiatric Comorbidity in Cocaine Dependence: Diverging Trends, Axis II Spectrum, and Gender Differentials , 1995 .

[96]  P. Jacob,et al.  Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. , 1993, Journal of clinical psychopharmacology.

[97]  M. Gold,et al.  New concepts in cocaine addiction: The dopamine depletion hypothesis , 1985, Neuroscience & Biobehavioral Reviews.

[98]  David R. Gastfriend,et al.  Buprenorphine Treatment of Opiate and Cocaine Abuse: Clinical and Preclinical Studies , 1993, Harvard review of psychiatry.

[99]  J. Jaffe,et al.  A controlled trial of buprenorphine treatment for opioid dependence. , 1992, JAMA.

[100]  K. Kirby,et al.  Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. , 1995, Journal of clinical psychopharmacology.

[101]  Millman Rb Evaluation and clinical management of cocaine abusers. , 1988 .

[102]  J. Mendelson,et al.  Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. , 1989, The Journal of clinical endocrinology and metabolism.